Four publications this week:

• Cost-effectiveness of DPYD genotyping prior to fluoropyrimidine-based treatment for colorectal cancer in Wales | link
• The cost and cost-effectiveness of whole-exome and whole-genome sequencing: a systematic literature review | link
• Comparative Costs and Diagnostic Yields of Next-Generation Sequencing Versus Muscle Biopsy for Multiplex Ligation-Dependent Probe Amplification-Negative Duchenne Muscular Dystrophy | link
• A Value-Based Evaluation Framework for Guiding the Adoption and Scale-Up of Cancer Genomics Interventions | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.